Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lannett said representatives from the company spoke with and received guidance from the FDA on the clinical advancement program of its biosimilar insulin glargine partnered product candidate.
read more
Sygnature Discovery is supporting Professor Sachin Gupte, a pharmacologist at the New York Medical College, in his endeavors to find a drug treatment for the lung damage that can result from COVID-19 infection.
read more
AdvantaPure is now a GORE STA-PURE Pump Tubing systems integrator for biopharm and pharmaceutical applications.
read more
Seven Bridges has been selected by the PanCAN to build a customized, integrated health data platform to accelerate pancreatic cancer research.
read more
ERT has announced the acquisition of APDM Wearable Technologies, a next-generation provider of wearables and digital biomarkers.
read more
Ovid Therapeutics announced a strategic research collaboration with Columbia University Irving Medical Center researchers to advance genetic based therapies for a range of rare neurological conditions.
read more
U-Protein Express announced the availability of its new recombinant SARS-CoV-2 proteins, and other proteins associated with COVID-19, for use by researchers globally.
read more
ChromaCode announced that the FDA has granted EUA of ChromaCode's HDPCR™ SARS-CoV-2 Real-Time PCR Assay.
read more
Taconic Biosciences announced local West Coast United States production of the immunodeficient CIEA NOG mouse® model.
read more
Amphastar announced the FDA has approved its ANDA for Succinylcholine Chloride Injection USP, 200 mg/10 mL Multiple-Dose Vial.
read more
Catalent has signed an agreement with Spicona to develop a virus-like protein (VLP)-based vaccine against COVID-19.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
HealthVerity has signed a multi-year Research Collaboration Agreement with the FDA to evaluate a range of different real-world datasets for their potential to inform the FDA's response to COVID-19.
read more
Molecule Holdings (MH) has secured North American distribution for one of the first COVID-19 IgM/IgG Antibody Rapid Tests to receive FDA/EUA approval.
read more
Panacea Biotec has announced a collaboration with Refana USA to make COVID-19 vaccine widely accessible around the world in an equitable manner through a Joint Venture company to be based in Ireland.
read more